RNS Number : 3564P
Judges Scientific PLC
21 May 2024
 

21 May 2024

Judges Scientific plc

(the "Group" or "Judges")

Result of Annual General Meeting and General Meeting

Judges Scientific (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector, announces that, at the Annual General Meeting ("AGM") held earlier today, all of the resolutions put to shareholders were duly passed. In addition, at the General Meeting held immediately after the AGM, all of the resolutions put to shareholders were duly passed.

The votes received at the AGM are detailed below:

Resolution

Votes for

%

Discretion

%

Votes against

%

Votes withheld

Resolution 1 (Ordinary)

To receive and, if approved, adopt the audited financial statements of the Company for the year ended 31 December 2023 and the reports of the Directors and auditor thereon.  

3,175,302

99.37

19,890

0.62

16

0.01

3,035

Resolution 2 (Ordinary)

To approve both the Remuneration Policy and the Remuneration Report (other than the part containing the Remuneration Policy) as respectively set out in the Annual Report and Accounts 2023.

3,067,573

95.93

19,890

0.62

110,354

3.45

426

Resolution 3 (Ordinary)

To re-appoint Susan Nyman, who was appointed by the Board on 21 November 2023, as a Director.

3,130,448

97.88

19,890

0.62

47,840

1.5

65

Resolution 4 (Ordinary)

To re-appoint Hon. Alexander Hambro, who retires by rotation, as a Director.

2,895,942

90.55

19,890

0.62

282,374

8.83

37

Resolution 5 (Ordinary)

To re-appoint Bradley Ormsby, who retires by rotation, as a Director.

3,064,925

95.83

19,890

0.62

113,404

3.55

24

Resolution 6 (Ordinary)

To re-appoint Mark Lavelle, who retires by rotation, as a Director.

3,031,351

94.78

19,890

0.62

146,978

4.6

24

Resolution 7 (Ordinary)

To re-appoint Lushani Kodituwakku, who retires by rotation, as a Director.

3,105,732

97.11

19,890

0.62

72,556

2.27

65

Resolution 8 (Ordinary)

To approve a final dividend of 68.0p per Ordinary share.

3,177,889

99.37

19,890

0.62

459

0.01

5

Resolution 9 (Ordinary)

To approve the re-appointment of BDO UK LLP as auditor to hold office formally from the conclusion of this meeting until the conclusion of the next

3,178,053

99.37

19,890

0.62

222

0.01

78

Resolution 10 (Special)

To authorise the directors to allot relevant securities

3,169,725

99.12

19,890

0.62

8,185

0.26

443

Resolution 11 (Special)

To disapply pre-emption rights

2,781,412

86.98

19,890

0.62

396,464

12.4

477

Resolution 12 (Special)

To resolve that the company be and is unconditionally authorised to make market purchases

3,106,989

99.28

19,890

0.64

2,385

0.08

68,979

 

The votes received at the General Meeting are detailed below:

Resolution

Votes for

%

Discretion

%

Votes against

%

Votes withheld

Resolution 1 (Special)

THAT article 21 of the Company's articles of association (the Articles) shall be deleted and replaced by inserting a new article 21

2,626,744

99.98

40

0.01

43

0.01

584

Resolution 2 (Special)

THAT article 22.5(a) of the Articles shall be amended to delete the words "by rotation or otherwise".

2,626,757

99.98

40

0.01

30

0.01

584

Resolution 3 (Special)

THAT article 26.2 of the Articles shall be amended to delete the words "by rotation"

2,626,394

99.98

40

0.01

43

0.01

934

Resolution 4 (Ordinary)

To re-appoint David Cicurel, who retires annually, as a Director.

2,535,410

96.51

40

0.01

91,436

3.48

525

Resolution 5 (Ordinary)

To re-appoint Tim Prestidge, who retires annually, as a Director.

2,532,678

96.41

40

0.01

94,168

3.58

525

Resolution 6 (Ordinary)

To re-appoint Ralph Elman, who retires annually, as a Director.

1,483,520

56.47

40

0.01

1,143,326

43.52

525

Resolution 7 (Ordinary)

To re-appoint Charles Holroyd, who retires annually, as a Director.

2,412,756

96.03

40

0.01

99,542

3.96

115,073

 

The Board notes that more than 20% of shareholders voted against resolution six at the General Meeting.  The Board intends to consult with shareholders to understand their views.

Details of the votes cast on all resolutions will also be available on the Company's website: www.judges.uk.com.

-     Ends -  

 

For further information please contact:

 

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 


Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000


Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

 



 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group now consists of 23 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMABMFTMTTTBAI